Literature DB >> 1628898

Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens.

C A Bate1, J Taverne, H J Bootsma, R C Mason, N Skalko, G Gregoriadis, J H Playfair.   

Abstract

The active component of the exoantigens of malarial parasites which stimulates macrophages to secrete tumour necrosis factor (TNF) has been shown to depend upon a phospholipid, the activity of which was blocked by phosphatidylinositol (PI) and inositol monophosphate (IMP) in competitive inhibition studies. Antisera made against the exoantigens of Plasmodium yoelii, which inhibited their induction of TNF, were found by an ELISA assay to contain antibody against several other phospholipids. However, the inhibitory antibody was removed specifically by adsorption with liposomes containing PI, but not other phospholipids. Furthermore, PI was the only phospholipid in non-liposomal form which induced the production of inhibitory antisera. Mice immunized with IMP, but not inositol, also produced inhibitory antisera. When incorporated into liposomes several other phospholipids did give rise to inhibitory antibodies but, in contrast to the antisera against parasite exoantigens, PI and IMP, the inhibitory activity was removed by adsorption with heterologous phospholipid liposomes, suggesting that it was directed against a common determinant, presumably the phosphate ester head group. Inhibitory antibodies in the antisera tested were predominantly IgM and titres were not increased after repeated injections. Antisera raised against PI, IMP or the cross-reacting phospholipid liposomes also inhibited TNF secretion by macrophages stimulated by exoantigens of the human parasites P. falciparum and P. vivax, but not by bacterial lipopolysaccharide. These findings confirm our conclusion that exoantigens from these different species contain phosphate bound to inositol in their TNF-inducing moiety.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628898      PMCID: PMC1421753     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Suppression of cytotoxicity of diphtheria toxin by monoclonal antibodies against phosphatidylinositol phosphate.

Authors:  R L Friedman; B H Iglewski; F Roerdink; C R Alving
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

2.  Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides.

Authors:  D C Morrison; D M Jacobs
Journal:  Immunochemistry       Date:  1976-10

Review 3.  Immunological adjuvants: a role for liposomes.

Authors:  G Gregoriadis
Journal:  Immunol Today       Date:  1990-03

4.  Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A.

Authors:  B G Schuster; M Neidig; B M Alving; C R Alving
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

5.  Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum.

Authors:  S Picot; F Peyron; J P Vuillez; G Barbe; K Marsh; P Ambroise-Thomas
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

6.  Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.

Authors:  J Taverne; C A Bate; D Kwiatkowski; P H Jakobsen; J H Playfair
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum.

Authors:  J Taverne; C A Bate; D A Sarkar; A Meager; G A Rook; J H Playfair
Journal:  Parasite Immunol       Date:  1990-01       Impact factor: 2.280

8.  Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.

Authors:  C A Bate; J Taverne; E Román; C Moreno; J H Playfair
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

9.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

10.  Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.

Authors:  C A Bate; J Taverne; A Davé; J H Playfair
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

View more
  19 in total

1.  Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction.

Authors:  Mark R Gillrie; Kristine Lee; D Channe Gowda; Shevaun P Davis; Marc Monestier; Liwang Cui; Tran Tinh Hien; Nicholas P J Day; May Ho
Journal:  Am J Pathol       Date:  2012-01-17       Impact factor: 4.307

2.  High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals.

Authors:  P H Consigny; B Cauquelin; P Agnamey; E Comby; P Brasseur; J J Ballet; C Roussilhon
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes.

Authors:  N A Sheikh; H N Caro; J Taverne; J H Playfair; T W Rademacher
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  Naive human alpha beta T cells respond to membrane-associated components of malaria-infected erythrocytes by proliferation and production of interferon-gamma.

Authors:  S Dick; M Waterfall; J Currie; A Maddy; E Riley
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

5.  A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 7.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria.

Authors:  C A Facer; G Agiostratidou
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

9.  Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice.

Authors:  H Perlmann; S Kumar; J M Vinetz; M Kullberg; L H Miller; P Perlmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria.

Authors:  R J Allan; P Beattie; C Bate; M B Van Hensbroek; S Morris-Jones; B M Greenwood; D Kwiatkowski
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.